Correlation Between Milestone Pharmaceuticals and Day One

Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Milestone Pharmaceuticals and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Day One.

Diversification Opportunities for Milestone Pharmaceuticals and Day One

0.26

Correlation Coefficient

Milestone Pharmaceuticals  Day One

Modest diversification

The 3 months correlation between Milestone and Day is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Day One go up and down completely randomly.

Pair Corralation between Milestone Pharmaceuticals and Day One

Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Day One. In addition to that, Milestone Pharmaceuticals is 2.25 times more volatile than Day One Biopharmaceuticals. It trades about -0.09 of its total potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.15 per unit of volatility. If you would invest  1,258  in Day One Biopharmaceuticals on December 28, 2024 and sell it today you would lose (451.00) from holding Day One Biopharmaceuticals or give up 35.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Milestone Pharmaceuticals  vs.  Day One Biopharmaceuticals

Milestone Pharmaceuticals

Risk-Adjusted Performance

Weak

Over the last 90 days Milestone Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Day One Biopharmaceu

Risk-Adjusted Performance

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Milestone Pharmaceuticals and Day One

The main advantage of trading using opposite Milestone Pharmaceuticals and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.

The idea behind Milestone Pharmaceuticals and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.